Your cart is empty.
Männedorf, Switzerland, October 11, 2011 – Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe. This collaboration covers the Attana 100, Attana 200 and Cell 200 instruments, as well as biosensors and assay reagents, service and support, extending the existing agreement for North America announced earlier this year. Exceptions to this agreement are Scandinavia and those countries covered by Tecan’s distributor network. This distribution agreement will ensure customers in these new markets can take advantage of QCM technology for analysis of molecular interactions in a wide variety of research applications, supported by Tecan’s sales, service and applications capabilities.
“We are pleased to announce this expansion only six months after our initial agreement with Tecan for North America,” commented Teodor Aastrup, CEO and founder of Attana. “This collaboration will strengthen Attana’s position in Europe through Tecan’s broad sales channels and local presence. Our products complement each other well, and we are able to offer customers a complete solution for biomolecular investigation.”
For more information please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2010, Tecan generated sales of CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019).
About Attana AB
Founded in 2002, based in Stockholm, Sweden, Attana AB develops biosensors for the pharmaceutical, diagnostic and academic society worldwide. With a strong focus on characterizing molecular interactions exactly as they occur in the human body, Attana is committed to increasing the success during clinical trials by providing the life science community with biologically relevant information. Attana’s biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria. For more information you may contact marketing manager at Attana: Gabriela Suhoschi:email@example.com, +46 8 674 57 12.